Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02663921 · ClinicalTrials.gov registry record · NA
Visible Light Study
A NA study of Skin Disease and Pigment Disorders, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT02663921: Completed NA study of Skin Disease and Pigment Disorders, sponsored by NYU Langone Health.
NCT02663921 is a NA study of Skin Disease and Pigment Disorders that has completed, run by NYU Langone Health. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02663921, a NA study of Skin Disease and Pigment Disorders, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn more about the potential effects of visible light on the skin. More specifically, this study will examine whether an incandescent lamp (light bulb) or LED light bulb can cause skin to become darker. Investigators will determine the minimum threshold dose required to achieve immediate pigmentation darkening (IPD), persistent pigmentation darkening (PPD), and delayed tanning (DT) for Fitzpatrick skin types IV - VI utilizing two visible light sources.
Conditions Studied
Interventions
- OTHER Part A: Baseline-Week 2
- OTHER Part B: Week 4-Week 12
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2015-09 |
| Est. Completion | 2019-04-17 |
| Phase | NA |
What the finished NCT02663921 record still lists
NCT02663921 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Skin Disease appearing as the primary indexed condition, and to 2 interventions - of which Part A: Baseline-Week 2 is the first listed.
NCT02663921 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02663921 about?
NCT02663921 is a clinical study titled "Visible Light Study". The purpose of this study is to learn more about the potential effects of visible light on the skin. More specifically, this study will examine whether an incandescent lamp (light bulb) or LED light bulb can cause skin to become darker. Investigators will determine the minimum threshold dose require...
What is the current status of trial NCT02663921?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2015-09. Estimated completion is 2019-04-17.
What conditions does trial NCT02663921 study?
This clinical trial studies the following conditions: Skin Disease, Pigment Disorders.
What interventions are being tested in trial NCT02663921?
The interventions under investigation include: Part A: Baseline-Week 2 (OTHER), Part B: Week 4-Week 12 (OTHER).
Who is sponsoring clinical trial NCT02663921?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02663921 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02663921's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia